Director, Head of U.S. Federal Government Affairs

At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.

Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.

Does this inspire you and feel like a fit? Then we would love to have you join us!

The Role & Department  

Director, Head U.S. Federal Government Affairs - Head Federal Lobbyist

Position Overview: Reporting directly to Head of Government Affairs and Policy, the Director, Head U.S. Federal Government Affairs will serve as Genmab’s senior representative in Washington, DC. This is a newly created, high-visibility leadership role responsible for building and executing Genmab’s first comprehensive federal lobbying and government affairs strategy as the company transitions to a fully integrated U.S. commercial organization.

Location: Washington, D.C.

Key Responsibilities:

· Develop and lead Genmab’s U.S. federal government affairs strategy, with initial focus for Congressional engagement on oncology reimbursement, Medicare Part B & Part D policy, IRA implementation and potential reforms, 340B and PBM reform, intellectual property protection (Bayh-Dole, march-in rights), pandemic preparedness/biodefense funding, BIOSECURE/BIOCOMPETE, etc.

· Directly lobby Congress (key committees: House Energy & Commerce, Senate HELP, Senate Finance, House Ways & Means, Appropriations) and relevant Administration agencies (CMS, FDA, HHS-OASH, CDER).

· Represent Genmab on relevant working groups and committees within PhRMA, BIO, Cancer coalitions, and other relevant trade associations and advocacy partnerships.

· Build and maintain strong bipartisan relationships on Capitol Hill and within the Administration, with particular emphasis on members and staff focused on oncology, intellectual property, and drug pricing policy.

· Partner closely with Genmab’s U.S. market access, medical affairs, regulatory, and commercial teams to anticipate and shape policy impacting current portfolio and late-stage pipeline.

· Serve as primary federal liaison with U.S. patient advocacy organizations.

· Collaborate with Head of U.S. Policy on legislative language, comment letters, position papers, congressional testimony, and briefing materials.

· Manage external contract lobbyists, political intelligence consultants, and grassroots vendors.

· Collaborate with Head of Government Affairs and Policy to the USLT, Commercial Leadership Team, and Executive Committee on U.S. policy/legislative developments and political risk.

· Lead Genmab PAC team to develop and oversee the startup, rollout, enrollment and overall success.

· Ensure full compliance with Lobbying Disclosure Act, FDA advertising/promotion rules affecting advocacy, and all Genmab policies.

Requirements:

· Bachelor’s degree from an accredited institution is required; JD, MPP, or relevant advanced degree highly desirable.

· 12+ years of progressive federal government affairs experience in biotechnology/pharmaceuticals.

· 5+ years in a senior leadership role.

· Proven success directly lobbying on oncology, Medicare reimbursement, drug pricing, and/or intellectual property issues.

· Existing bipartisan relationships with key members and staff on Energy & Commerce, HELP, Finance, Ways & Means, and Appropriations committees.

· Deep policy expertise in MFN, Medicare Part B buy-and-bill, IRA price-setting provisions, 340B, patent/evergreening debates, and Bayh-Dole/march-in rights.

· Experience representing international or emerging biotech companies strongly preferred.

· Prior Hill (committee or personal office) or senior Administration experience (HHS, CMS, FDA) is strongly preferred.

Ideal Candidate:

· Entrepreneurial, hands-on leader comfortable building a function from the ground up in a lean, fast-moving organization.

· Scientifically curious with the ability to translate complex antibody biology and clinical data into compelling policy narratives.

· Exceptional judgment, integrity, and leadershi